Surgical robotic made in India achieves significant milestone of 100 cardiac surgeries
iNDICA NEWS BUREAU-
The made-in-India surgical robotic system SSI Mantra, India’s first robotic surgery system developed by SS Innovations, has achieved the feat by successfully performing 100 robotic cardiac surgery procedures. This remarkable achievement was announced by the company on Thursday, May 23.
Dr. Sudhir Srivastava, Chairman and CEO of SS Innovations, emphasized the significance of this milestone. He stated, “Reaching this milestone with the SSI Mantra is another notch in SS Innovations’ strategic market expansion. Our goal is to transform surgical practices, enhance access, and drive the widespread adoption of robotic surgery.”
According to Dr Srivastava, the SSI Mantra’s innovative design features a unique fifth-arm capability. This enables it to perform complex cardiac surgeries – a high-demand market that previously lacked effective robotic solutions. Traditionally, cardiac surgery often involves a maximally invasive approach that requires the patient’s sternum splitting to gain access.
The advanced SSI Mantra system has been used in over 1,000 procedures globally. Among its successful executions are procedures such as Totally Endoscopic Coronary Artery Bypass (TECAB), Internal Mammary Artery (IMA) Takedown, Mitral Valve Replacement, and Bilateral Internal Mammary Artery (BIMA) Takedown.
“Our focus is on precise execution, minimizing trauma, reducing blood loss, enabling quicker recoveries, and achieving superior overall outcomes – all while maintaining cost-effectiveness,” Dr Srivastava stated while adding that the company anticipates US FDA approval and CE Mark certification in Europe by early 2025.
The global surgical robotics market is on a robust growth trajectory. According to ResearchAndMarkets, the global surgical robotics market its size was valued at $78.8 billion in 2022 and is projected to reach $188.8 billion by 2032, growing at a CAGR of 9.1 percent from 2023 to 2032.
